Quality Control Testing

Quality Control Testing
Product Description

Bringing a compound from the laboratory to the market is a long and winding road with a great number of scientific, safety and regulatory challenges. SGS has been offering high quality analytical testing and clinical research services to support drug research, registration and production. 
SGS leverages its conveniently located network of laboratories and clinical trial facilities present in North America, Europe and Asia-Pacific, to deliver harmonized solutions to large pharmaceutical and biotechnology firms.


 Our experts provide effective and efficient testing solutions for analytical development, biologics characterization, biosafety and quality control, as well as clinical research services. We perform a variety of tests that are bespoke, client-specific and support the full clinical development, from Phase I First-in-Human trials in our Clinical Pharmacology Units to Phase II and Phase III studies in patients.

SGS Group Management SA

  • CH
  • 2020
    On CPHI since
  • 5000+
    Employees
Company types
Other
Primary activities
Analytical Services
Specifications
  • Supplied from
    Belgium; Canada; China; France; Germany; India; United Kingdom; United States

SGS Group Management SA

  • CH
  • 2020
    On CPHI since
  • 5000+
    Employees
Company types
Other
Primary activities
Analytical Services

More Products from SGS Group Management SA (4)

  • Extractables & Leachables

    Product Extractables & Leachables

    Extractables & leachables studies enable drug sponsors to quantify and identify the risks of potentially toxic leachable impurities migrating into a drug solution from container closure systems, processing equipment or packaging. Regulatory bodies such as the US Food and Drug Administration (FDA) and T...
  • Biosafety Testing

    Product Biosafety Testing

    Life-saving medicines are heavily regulated during development, manufacture and distribution. To fulfill regulatory requirements, the biopharmaceutical industry is increasingly looking for independent service providers who can deliver comprehensive characterization solutions on one site. 
    SGS’s glo...
  • Viral Safety Testing

    Product Viral Safety Testing

    SGS’s global center of excellence for cell bank characterization & virus testing is located in the United Kingdom and provides services with ultimate reliability, highest GLP/cGMP quality & scientific expertise.

    For any of your biologics, we help you comply with the global regula...
  • Biologics Charaterization

    Product Biologics Charaterization

    A full package of Biologics testing services to cGMP standards from early phase characterization including Biosafety to Quality Control release testing enabling you to outsource your biologics.

SGS Group Management SA resources (2)

  • News SGS Joins Oxford University Consortium Led by the Jenner Institute to Develop COVID-19 Vaccine

    In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov-19
  • Brochure Analytical Testing and Quality Control Solutions

    Bringing a compound from the laboratory to the market is a long and winding road with a great number of scientific, safety and regulatory challenges. SGS has been offering high quality analytical testing and clinical research services to support drug research, registration and production. 
    SGS leverages its conveniently located network of laboratories and clinical trial facilities present in North America, Europe and Asia-Pacific, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. 
    Our experts provide effective and efficient testing solutions for analytical development, biologics characterization, biosafety and quality control, as well as clinical research services. We perform a variety of tests that are bespoke, client-specific and support the full clinical development, from Phase I First-in-Human trials in our Clinical Pharmacology Units to Phase II and Phase III studies in patients.